The optometric care has been evolving with new innovations these last couple of years.
With improved technology healthcare professionals are able to provide patients with improved care and comfort. These new innovations have helped to change and improve the way an optometrist can manage or treat certain eye diseases. The OCT and Retinal Camera has allowed optometrists to diagnose and detect early signs of treatable eye conditions. This technology has allowed for better outcomes for disease treatment because of early detection and increased specificity.
Having the newest technology is essential in diagnosing and managing many types of eye diseases. Certain eye conditions prognosis is dictated by early detection and treatment. These new innovations will help detect and diagnosis certain eye conditions so the best treatment outcome can be provided towards each one of our patients.
CIRRUS HD-OCT 500
The CIRRUS HD-OCT 500 offers comprehensive care practices essential OCT capabilities with a broad range of clinical applications in an easy-to-learn, easy-to-use instrument.
It aids in the management of glaucoma, retinal disease and anterior segment imaging for corneal disease.
NM-1000 OPTOS CALIFORINA CAMERA
Our Optos California camera has a new UWF optomap imaging modality; Indocyanine Green angiography (icg) while retaining:
• Composite color • Red-free • Autoﬂuorescence (af)
• Fluorescein angiography (fa)
The biggest advantage of the Optos California camera is that it has the ability to capture the largest field of view possible in one image. Our eye care professionals are now able to see 50% more of the retina when compared to other conventional imaging devices.This allows our doctors to proactively detect and diagnose our patients more efficiently.California allows us the ability to:
• Compact to reduce space requirements. • New design leads to ease of use and faster image capture. • Non-mydriatic high-resolution imaging through many cataracts and/or 2mm pupils saves time in busy practices. • Browser-based image review enables simple integration and easy access to your data from any connected pc or tablet in a HIPAA compliant environment. • Interweaved angiography enables parallel capture of fa and icg images without manually switching between imaging modalities.
Humphrey Visual Field (HVF)
Providing advanced analysis with comprehensive connectivity options validated by more than 30 years of research, design and clinical experience, the Humphrey® Field Analyzer (HFA™) is the accepted standard of care in glaucoma diagnosis and management. With over 65,000 installed units worldwide, the HFA is the premier automated visual field analyzer. A visual field test is an eye examination that can detect dysfunction in central and peripheral vision.
Additionally, the Humphrey Visual Field (HVF) is a special automated procedure used to measure the entire area of peripheral vision that can be seen when an eye is focused on a central point. This machine assists in diagnosing and monitoring neurological conditions such as pituitary tumors, optic neuropathies, strokes and more.
Nidek ARK-530A Autorefractor
The combination of new measuring principle - Pupil Zone Imaging Method - and unique technology - SLD - offers high accuracy and reliability in refraction measurement.
The NIDEK ARK-530A also adopts the advanced Pupil Zone Imaging Method for refraction measurement, which analyzes a wider area (Max. ø4 mm) to obtain more reliable and realistic data that is closer to subjective refraction.
HRT Heidelberg Retinal Tomography
Heidelberg Retinal Tomography is a diagnostic procedure used for precise observation and documentation of the optic nerve head, essential for the diagnosis and management of glaucoma. The HRT uses a special laser to take 3-dimensional photographs of the optic nerve and surrounding retina. This laser, which will not harm the eye, is focused on the surface of the optic nerve and captures the image.
The HRT takes images of deeper and deeper layers until the desired depth has been reached. Finally, the instrument takes all these pictures of the layers and puts them together to form a 3D image of the entire optic nerve.
BlephEx™ is a revolutionary new patented hand piece, used to very precisely and carefully, spin a medical grade micro-sponge along the edge of your eyelids and lashes, removing scurf and debris and exfoliating your eyelids.
BlephEx™ is a very useful addition to the lid hygiene / dry eye armamentarium. The device effectively clears debris from the lashes and lid margins and to my surprise contributes to down-regulating inflammation along with a subjective improvement in symptoms.
InflammaDry is the first and only, rapid result, in-office test that detects elevated levels of MMP-9, an inflammatory marker that is consistently elevated in the tears of patients with dry eye disease. All other dry eye tests measure tear production and stability.
Using a simple 4-step process, InflammaDry recognizes elevated levels of MMP-9, to identify patients that may otherwise be missed with other dry eye testing methods.
TearLab is an objective and quantitative point-of-care diagnostic test that provides precise and predictive information.
The TearLab Osmolarity System* is intended to measure the osmolarity of human tears to aid in the diagnosis of dry eye disease in patients suspected of having dry eye disease, in conjunction with other methods of clinical evaluation.
*TearLab is for professional in vitro diagnostic use only.
ANTARES new corneal topographer with advanced tear-film analysis. Boasts a new high resolution digital colour camera and advanced algorithms, to bring you user friendly, full featured Corneal Topographic data, TBUT analysis, as well as MGD analysis.
- Corneal Topography
- Contact lens fitting with Autofit
- Keratoconus screening with classification
- Dynamic view of non-invasive break-up time
- Tear Meniscus Height Imaging and Measurement
- Interference Pattern Imaging of Lipid Layer
- Imaging of the Tear Film Dynamics (Video)
- Fluorescein Imaging
- Meibomian Glands Imaging and Analysis
DID YOU KNOW?
Cataracts are often seen in people over the age of 55, but can be evident in the younger population.